The Rifampin for Injection, cataloged under National Stock Number 6505-01-692-6794, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sanofi Pasteur Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: VI.
| Parameter | Value |
|---|---|
| NSN | 6505-01-692-6794 |
| Primary Part Number | NDC00068-0597-01 |
| Item Name | Rifampin for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sanofi Pasteur Inc. |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 60.000 MILLILITERS AFTER RECONSTITUTION |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | VI |
| Part Number | Manufacturer |
|---|---|
| NDC00068-0597-01 PRIMARY | Sanofi Pasteur Inc. (USA) |
| NDC63323-0351-20 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1587801 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM206702 | 5/1 Secondary reference Defense Medical Standardization Board |
| RIFADIN IV | 5/1 Secondary reference Sanofi Pasteur Inc. |
NSN 6505-01-692-6794 is a Rifampin for Injection, manufactured by Sanofi Pasteur Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-692-6794 has 2 manufacturer part numbers on file: NDC00068-0597-01 (Sanofi Pasteur Inc.), NDC63323-0351-20 (Fresenius Kabi, Llc).
Key specifications for NDC00068-0597-01: Administration: INTRAVENOUS; Primary Container Content Quantity: 60.000 MILLILITERS AFTER RECONSTITUTION; Features Provided: STERILE; Primary Container Type: VIAL. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.